Status:
ACTIVE_NOT_RECRUITING
External Validation of Ten Prediction Models for 30-day Mortality Following Hip Fracture
Lead Sponsor:
JointResearch
Conditions:
Hip Fracture
Hip Fracture Surgeries
Eligibility:
All Genders
18+ years
Brief Summary
This study aims to externally validate ten existing prediction models with a low risk of bias for 30-day mortality following hip fracture. Data will be collected from the Dutch Hip Fracture Audit (DHF...
Detailed Description
Hip fractures are a major health concern, especially among older adults, and are associated with substantial morbidity, mortality, and healthcare costs. While surgical intervention is standard practic...
Eligibility Criteria
Inclusion
- Patients admitted to OLVG between January 1, 2016, and March 1, 2024, with a diagnosis of hip fracture; and/or.
- Patients who underwent surgery at OLVG between January 1, 2016, and March 1, 2024, with an indication of hip fracture; and.
- Availability of independent predictor variables for at least one of the selected prediction models in the medical record.
Exclusion
- Patients with unknown 30-day follow-up mortality status.
- Patients with periprosthetic fractures (fractures around an existing hip prosthesis) at the time of presentation.
- Patients aged under 18 years at the time of hip fracture.
- Patients who declined the use of their medical data for research purposes.
Key Trial Info
Start Date :
June 1 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 1 2026
Estimated Enrollment :
3500 Patients enrolled
Trial Details
Trial ID
NCT06961253
Start Date
June 1 2024
End Date
June 1 2026
Last Update
November 17 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
OLVG
Amsterdam, Netherlands, 1091AC